Neuroinflammation mediated by IL-1β increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease

The rat brain in stereotaxic coordinates

Palkovits, M. (1983) · Neuropeptides · doi:10.1016/0143-4179(83)90049-5 · Cited by 28,959

The Rat Brain in Stereotaxic Coordinates

Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585

Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227

Microglia: a sensor for pathological events in the CNS

Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396

Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1

Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481

Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology

Zimprich, A. A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M. J., Lincoln, S., Kachergus, J. M., Hulihan, M., Uitti, R. J., Calne, D. B., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.11.005 · Cited by 3,088

Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator

West, M. J., Slomianka, L., & Gundersen, H. J. G. (1991) · The Anatomical Record · doi:10.1002/ar.1092310411 · Cited by 2,994

Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990

Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism

Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C. J., Squitieri, F., Ibáñez, P., Joosse, M., et al. (2003) · Science · doi:10.1126/science.1077209 · Cited by 2,854

Is Chronic Systemic Inflammation a Determinant Factor in Developing Parkinson’s Disease?

Ugalde‐Muñiz, P., Pérez‐Hernández, J., & Chavarría, A. (2016) · InTech eBooks · doi:10.5772/62955 · Cited by 1

Growth factors and their receptors

Lazaldin, M. A. M., Lambuk, L., Ahmad, S., & Mohamud, R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18677-6.00005-1 · Cited by 1

Accelerated senescence exacerbates α-synucleinopathy in senescence-accelerated prone 8 mice via persistent neuroinflammation

Sakiyama, H., Baba, K., Kimura, Y., Ogawa, K., Nishiike, U., Hayakawa, H., Yoshida, M., Aguirre, C., Ikenaka, K., Nagano, S., et al. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105906 · Cited by 1

Vitamin D and Parkinson's disease

Gonçalves, V., Scorza, F. A., de Almeida, A.-C. G., & Scorza, C. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89835-5.00031-4 · Cited by 1

SIGNALING PATHWAYS INVOLVED IN IL-1BETA- INDUCED REGULATION OF MOR EXPRESSION IN HUMAN NEURONS By

Mohan, S., Hertfordshire, H., & Uk, E. (2008) · SHAREOK (University of Oklahoma; Oklahoma State University; Central Oklahoma University) · Cited by 1

Lewy Body Formation through the lens of Cytokine-Mediated Neuroinflammation in Parkinson's Disease DevelopmentPreprint

Shafi, V. (2024) · Research Square · doi:10.21203/rs.3.rs-4232044/v1 · Cited by 1

Transcriptional pathobiology and multi-omics predictors for Parkinson’s diseasePreprint

Hu, R., Wang, R., Yuan, J., Lin, Z., Hutchins, E. D., Landin, B., Liao, Z., Liu, G., Scherzer, C. R., & Dong, X. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.18.599639 · Cited by 1

Effects of Alpha-Synuclein on Cellular Homeostasis

Vekrellis, K., Minakaki, G., & Emmanouilidou, E. (2011) · InTech eBooks · doi:10.5772/17637

Inflammation in Parkinson’s Disease: Causes and Consequences

Louise, M., Toulouse, A., & Yvonne, M. (2012) · InTech eBooks · doi:10.5772/18184

A Biomaterials Approach for an Ex-Vivo Multiple Sclerosis Model of Inflammatory Demyelination

Mathew, A. (2013) · ARAN (University of Galway Research Repository) (Ollscoil na Gaillimhe – University of Galway) · doi:10.13025/17941

Compensatory Mechanisms and T Cell Migration In Mouse Models of Dopaminergic Loss

Anderson, K. M. (2015) · DigitalCommons@UNMC

LRRK-2 as a Key Molecule Bridging Inflammation to Parkinson's Disease

Roca, V., & Puntel, M. (2013) · Advances in Neuroimmune Biology · doi:10.3233/nib-130067

Role of Adenosine A2A Receptors in the Control of Neuroinflammation—Relevance for Parkinson’s Disease

Gomes, C. A., George, J., Chen, J., & Cunha, R. A. (2015) · Current topics in neurotoxicity · doi:10.1007/978-3-319-20273-0_5

Review Article Brain angiotensin and dopaminergic degeneration: relevance to Parkinson's disease

Labandeira-García, J. L., Rodríguez‐Pallares, J., Rodriguez-Perez, A. I., Garrido‐Gil, P., Valenzuela, R., & Guerra, M. J. (2012)

Effects of Anti-viral Acute Phase Response on Hippocampal Glutamate Regulation

Hunsberger, H. C. (2016) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.5839

Hyaluronan and CD44 control of cell fate

Woods, E. L. (2016) · ORCA Online Research @Cardiff (Cardiff University)

Short communication Interrupting the inflammatory cycle in chronic diseases e Do gap junctions provide the answer

Green, C. R. (2008)

Investigating Saporin-Conjugated Quantum Dots as a Microglia Depletion Strategy in the Substantia Nigra

Landrigan, J. (2017) · doi:10.22215/etd/2017-12095

Functional facets of dopaminergic system and cancer. Part 1

Bocharov, E. V., Кучеряну, В. Г., & Bocharova, O. A. (2017) · Zhurnal «Patologicheskaia fiziologiia i eksperimental`naia terapiia» · doi:10.25557/0031-2991.2017.03.116-126

Roles in Immune Responses

Hanamsagar, R., Cardona, S. M., Kielian, T., & Cardona, A. E. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1429-6_5

Blood Biomarker and Physical Activity Correlations in Persons with Parkinson’s Disease

Morales, J. (2024) · The Boller Review · doi:10.18776/tcu/br/7/170

Astrocytes in multiple sclerosis

Piester, G., & Quintana, F. J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-823848-6.00010-5

Animal Models for the Study of Neurological Diseases and Their Link to Sleep

Rubio, C., González-Sánchez, E., Lee, Á., Ponce-Juárez, A., Serrano‐García, N., & Rubio‐Osornio, M. (2025) · Biomedicines · doi:10.3390/biomedicines13082005

Dendritic Cells Induce Clec5a-mediated Immune Modulation in MPTP-induced Parkinson’s Disease Mouse Model

Choi, S.-Y., Nam, J.-H., Song, M.-S., Lee, J., Noh, K.-E., Oh, J.-S., Jung, N.-C., Song, J. Y., & Lim, D. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl39570

Additional file 12 of 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes

Bowles, K. R., Pugh, D. A., Liu, Y., Patel, T., Renton, A. E., Bandrés‐Ciga, S., Gan‐Or, Z., Heutink, P., Siitonen, A., Bertelsen, S. E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20329492

Additional file 3 of 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes

Bowles, K. R., Pugh, D. A., Liu, Y., Patel, T., Renton, A. E., Bandrés‐Ciga, S., Gan‐Or, Z., Heutink, P., Siitonen, A., Bertelsen, S. E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20329513

Additional file 15 of 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes

Bowles, K. R., Pugh, D. A., Liu, Y., Patel, T., Renton, A. E., Bandrés‐Ciga, S., Gan‐Or, Z., Heutink, P., Siitonen, A., Bertelsen, S. E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20329501

Additional file 8 of 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes

Bowles, K. R., Pugh, D. A., Liu, Y., Patel, T., Renton, A. E., Bandrés‐Ciga, S., Gan‐Or, Z., Heutink, P., Siitonen, A., Bertelsen, S. E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20329528

Additional file 11 of 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes

Bowles, K. R., Pugh, D. A., Liu, Y., Patel, T., Renton, A. E., Bandrés‐Ciga, S., Gan‐Or, Z., Heutink, P., Siitonen, A., Bertelsen, S. E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20329489

Additional file 7 of 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes

Bowles, K. R., Pugh, D. A., Liu, Y., Patel, T., Renton, A. E., Bandrés‐Ciga, S., Gan‐Or, Z., Heutink, P., Siitonen, A., Bertelsen, S. E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20329525

Additional file 10 of 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes

Bowles, K. R., Pugh, D. A., Liu, Y., Patel, T., Renton, A. E., Bandrés‐Ciga, S., Gan‐Or, Z., Heutink, P., Siitonen, A., Bertelsen, S. E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20329483

Additional file 1 of Pharmacological inhibition of nSMase2 reduces brain exosome release and α-synuclein pathology in a Parkinson’s disease model

Zhu, C., Bilousova, T. V., Focht, S., Jun, M., Elias, C. J., Melnik, M., Chandra, S., Campagna, J. J., Cohn, W., Hatami, A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14450653

Additional file 9 of 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes

Bowles, K. R., Pugh, D. A., Liu, Y., Patel, T., Renton, A. E., Bandrés‐Ciga, S., Gan‐Or, Z., Heutink, P., Siitonen, A., Bertelsen, S. E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20329531

Additional file 4 of 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes

Bowles, K. R., Pugh, D. A., Liu, Y., Patel, T., Renton, A. E., Bandrés‐Ciga, S., Gan‐Or, Z., Heutink, P., Siitonen, A., Bertelsen, S. E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20329516

Additional file 14 of 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes

Bowles, K. R., Pugh, D. A., Liu, Y., Patel, T., Renton, A. E., Bandrés‐Ciga, S., Gan‐Or, Z., Heutink, P., Siitonen, A., Bertelsen, S. E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20329498

Additional file 1 of 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes

Bowles, K. R., Pugh, D. A., Liu, Y., Patel, T., Renton, A. E., Bandrés‐Ciga, S., Gan‐Or, Z., Heutink, P., Siitonen, A., Bertelsen, S. E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20329504

Additional file 6 of 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes

Bowles, K. R., Pugh, D. A., Liu, Y., Patel, T., Renton, A. E., Bandrés‐Ciga, S., Gan‐Or, Z., Heutink, P., Siitonen, A., Bertelsen, S. E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20329522

Additional file 5 of 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes

Bowles, K. R., Pugh, D. A., Liu, Y., Patel, T., Renton, A. E., Bandrés‐Ciga, S., Gan‐Or, Z., Heutink, P., Siitonen, A., Bertelsen, S. E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20329519

Additional file 1 of An allosteric interleukin-1 receptor modulator mitigates inflammation and photoreceptor toxicity in a model of retinal degeneration

Dabouz, R., Cheng, C. W. H., Abram, P., Omri, S., Cagnone, G., Sawmy, K. V., Joyal, J., Desjarlais, M., Olson, D. M., Weil, A. G., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13297102

Additional file 2 of 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes

Bowles, K. R., Pugh, D. A., Liu, Y., Patel, T., Renton, A. E., Bandrés‐Ciga, S., Gan‐Or, Z., Heutink, P., Siitonen, A., Bertelsen, S. E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20329510

Additional file 13 of 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes

Bowles, K. R., Pugh, D. A., Liu, Y., Patel, T., Renton, A. E., Bandrés‐Ciga, S., Gan‐Or, Z., Heutink, P., Siitonen, A., Bertelsen, S. E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20329495

Extracellular ATP in neurodegenerative disorders

Boué‐Grabot, É., & Carracedo, S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-30250-3.00021-7

Circulating extracellular vesicles drive microglial senescence and neurodegeneration in Parkinson’s diseasePreprint

Yadav, A., Vacchi, E., Pinton, S., Lazzarini, E., Pecoraro, M., Raimondi, A., Barile, L., Kaelin‐Lang, A., & Melli, G. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.10.709299 · Cited by 1

Rôle de l'interleukine - 1 bêta dans la dégénérescence des photorécepteurs associée à la dégénérescence maculaire liée à l'âge

Charles‐Messance, H. (2018) · theses.fr (ABES) · doi:10.70675/674377b7z4bf8z451cz9328zbe6648512747

Étude des propriétés antioxydante et anti-inflammatoire de l’huile d’argan dans la dérégulation du métabolisme peroxysomal

Essadek, S. (2023) · theses.fr (ABES) · doi:10.70675/1012cea3z0890z4716z979ezfc08d8732999

Characterising the role of alpha synuclein in Ferroptosis, in the context of Parkinson's Disease

Mahoney‐Sanchez, L. (2022) · theses.fr (ABES) · doi:10.70675/a7f080d0z9ffaz4e1ez9550z0e29c4958e66

Rôle du métabolisme des acides gras polyinsaturés et du fer dans la vulnérabilité des neurones dopaminergiques à la ferroptose : nouvelles approches pharmacologiques pour la maladie de Parkinson.

Bouchaoui, H. (2024) · theses.fr (ABES) · doi:10.70675/e68098e9z03c2z494bza798zfc26b3eb872c

Micro- and nanoplastics as environmental modifiers of neuroimmune dysfunction in Parkinson’s disease

Qian, S., Gao, F., & Wang, P. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1886999

Brain-muscle axis regulation of neuroinflammation and sarcopenia in Parkinson’s disease: the bridging role of lactylation

Wang, M., Huang, H., Lan, X., Yin, A., Deng, Q., Zhong, Y., & Wang, M. (2026) · Neurological Sciences · doi:10.1007/s10072-026-09199-7

Neuroprotective Effects of Polyphenol-Rich Corinthian Currant Against a Rotenone Parkinson’s Disease Model: Mitigation of MAO-B and Pro-Inflammatory Cytokines Upregulation in Motor and Limbic Brain Regions

Fanarioti, Ε., Tsarouchi, M., Mountaki, C., Karathanos, V. Τ., Chroni, A., & Dermon, C. R. (2026) · Antioxidants · doi:10.3390/antiox15070906

Integrated meta-analysis of human astrocytes transcriptomes reveals a candidate recurrent inflammatory signature in response to inflammatory and immune stimuli

Luque-Bolivar, A., Ruiz-Araujo, K., Aristizábal-Pachón, A. F., & González, J. (2026) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2026.1870142

Synthetic Cannabinoids and the Purinergic–Dopaminergic Axis: P2x7 as a Candidate Primary Sensor of Neuroinflammatory Injury and the Role of Adenosine Receptor Heteromers in Emerging Nps Toxicity—A Hypothesis-Driven Integrative Review

Heemann, F. (2026) · Psychoactives · doi:10.3390/psychoactives5040029

The phenyl carbamates JBPOS0101 and JBPOS0607 attenuate rotenone-induced dopaminergic neuronal death in mice

Lee, J. H., Jeong, J. H., Mun, B.-R., Jang, J. K., Choi, Y. M., Baek, J.-H., & Choi, W.-S. (2026) · Brain Research · doi:10.1016/j.brainres.2026.150555

Prenatal origins of neurodegeneration: The role of maternal immune activation in Alzheimer's and Parkinson's pathobiology

Shehu, K., Onimisi, O. B., Bunza, H. A., Umar, S. M., Oyem, J. C., & Adeyeye, T. A. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.116029

Journal of Neuroinflammation BioMed Central

Koprich, J. B., Reske-Nielsen, C., Mithal, P., Isacson, O., Mithal, P., & Isacson, O. (2008)

Inflammatory Animal Model for Parkinson's Disease: The Intranigral Injection of LPS Induced the Inflammatory Process along with the Selective Degeneration of Nigrostriatal Dopaminergic Neurons

Machado, A., Herrera, A. J., Venero, J. L., Santiago, M., de Pablos, R. M., Villarán, R. F., Espinosa‐Oliva, A. M., Argüelles, S., Sarmiento, M., Delgado‐Cortés, M. J., et al. (2011) · ISRN Neurology · doi:10.5402/2011/476158 · Cited by 47

Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson’s disease

Pott Godoy, M. C., Tarelli, R., Ferrari, C. C., Sarchi, M. I., & Pitossi, F. J. (2008) · Brain · doi:10.1093/brain/awn101 · Cited by 335

doi:10.5402/2011/476158 Review Article Inflammatory Animal Model for Parkinson’s Disease: The Intranigral Injection of LPS Induced the Inflammatory Process along with the Selective Degeneration of

Neurology, I., & Neurons, N. D. (2013)

Lipopolysaccharide (LPS)-induced dopamine cell loss in culture: roles of tumor necrosis factor-α, interleukin-1β, and nitric oxide

Gayle, D. A., Ling, Z., Tong, C. W., Landers, T. M., Lipton, J. W., & Carvey, P. M. (2002) · Developmental Brain Research · doi:10.1016/s0165-3806(01)00315-7 · Cited by 201